<!doctype html>
 <html>
 <head>
 <meta charset='UTF-8'>
 <title>Bio</title>
 <style type='text/css'>
 	.in-bio-photo{
     width: 200px;
     height: 200px;
     border-radius: 100%;
     text-align: center;
 }	
 </style>
 </head>
  <body>
 <p style='text-align: center'><img class='in-bio-photo' src='/dtm/bios/2022/heise.jpg' alt='speaker-headshot'/></p><p style='text-align: center; font-weight: bold;'>Tim Heise, MD<br/>Profil Institute for Clinical Research, Neuss, Germany</p><p>
 Dr Heise is Lead Scientist, Chairman of the Board of Directors and co-founder of the private research institute Profil in Neuss, Germany. Profil has gained an international reputation for performing early-phase studies, in particular glucose clamp studies, investigating experimental diabetes treatments and medical devices. Dr Heise has led numerous studies on the pharmacology of novel anti-diabetic agents and insulins</p><p>Before establishing Profil, Dr Heise worked for more than 7 years at the Clinic for Nutrition and Metabolic Diseases at the Heinrich-Heine-University D&uuml;sseldorf (Head Prof Michael Berger). During this time, he was responsible for the diabetes and obesity outpatient clinics and took care of patients in structured teaching and treatment programs for type 1 and type 2 diabetes.</p><p>Dr Heise has published more than 250 scientific papers and reviews. He is a member of the Editorial Boards of Diabetes, Obesity and Metabolism, and Diabetes Technology &amp; Therapeutics.</p>
 </body>
 </html>